{
  "config": {
    "clinical_question": "Compare the effectiveness of letrozole+palbociclib with letrozole+ribociclib for the first line treatment of metastatic ER positive breast cancer.",
    "dataset_size": 1000,
    "treatment_effect_prob": 0.2,
    "target_treatment_rate": 0.5,
    "target_control_outcome_rate": 0.5,
    "enforce_positivity": false,
    "min_treatment_rate_per_stratum": 0.1,
    "max_treatment_rate_per_stratum": 0.9,
    "main_coefficient_scale": 0.3,
    "interaction_coefficient_scale": 0.1,
    "target_logit_std": 2.0,
    "num_confounders": 10,
    "outcome_type": "binary",
    "outcome_noise_std": 1.0,
    "output_dir": "../example_synthetic_data_ten_confounders",
    "llm": {
      "api_base_url": "http://localhost:8000/v1",
      "api_key": "",
      "model_name": "openai/gpt-oss-120b",
      "temperature": 0.7,
      "max_tokens": 30000,
      "timeout": 300.0
    },
    "seed": 42
  },
  "confounders": [
    {
      "name": "age",
      "type": "continuous",
      "description": "Patient age in years at initiation of first‑line therapy"
    },
    {
      "name": "ecog_performance_status",
      "type": "categorical",
      "categories": [
        "0",
        "1",
        "2",
        "3"
      ],
      "description": "Eastern Cooperative Oncology Group performance status score at baseline"
    },
    {
      "name": "menopausal_status",
      "type": "categorical",
      "categories": [
        "pre‑menopausal",
        "peri‑menopausal",
        "post‑menopausal"
      ],
      "description": "Menopausal state influencing choice of endocrine backbone"
    },
    {
      "name": "visceral_metastasis_site",
      "type": "categorical",
      "categories": [
        "bone‑only",
        "liver",
        "lung",
        "multiple_viscera"
      ],
      "description": "Anatomical location of metastatic disease at treatment start"
    },
    {
      "name": "prior_adjuvant_endocrine_therapy",
      "type": "categorical",
      "categories": [
        "none",
        "tamoxifen",
        "aromatase_inhibitor",
        "sequential"
      ],
      "description": "Type of adjuvant endocrine therapy received before metastatic recurrence"
    },
    {
      "name": "baseline_neutrophil_lymphocyte_ratio",
      "type": "continuous",
      "description": "Pre‑treatment NLR, a marker of systemic inflammation"
    },
    {
      "name": "charlson_comorbidity_index",
      "type": "continuous",
      "description": "Weighted score summarizing the burden of baseline comorbid conditions"
    },
    {
      "name": "baseline_alt_level",
      "type": "continuous",
      "description": "Serum alanine aminotransferase (ALT) measured in U/L prior to therapy"
    },
    {
      "name": "her2_status",
      "type": "categorical",
      "categories": [
        "negative",
        "positive",
        "equivocal"
      ],
      "description": "HER2 receptor status of the tumor (may affect physician’s CDK4/6 inhibitor preference)"
    },
    {
      "name": "insurance_type",
      "type": "categorical",
      "categories": [
        "private",
        "medicare",
        "medicaid",
        "uninsured"
      ],
      "description": "Primary payer category, reflecting socioeconomic access to specific CDK4/6 inhibitors"
    }
  ],
  "treatment_equation": {
    "intercept": 2.478127158119055,
    "coefficients": {
      "age": -0.2960061600674722,
      "ecog_performance_status_1": -0.5920123201349444,
      "ecog_performance_status_2": -1.7760369604048334,
      "ecog_performance_status_3": -3.5520739208096668,
      "visceral_metastasis_site_liver": -1.1840246402698889,
      "visceral_metastasis_site_lung": -0.5920123201349444,
      "visceral_metastasis_site_multiple_viscera": -1.7760369604048334,
      "prior_adjuvant_endocrine_therapy_tamoxifen": 1.1840246402698889,
      "prior_adjuvant_endocrine_therapy_aromatase_inhibitor": -0.5920123201349444,
      "prior_adjuvant_endocrine_therapy_sequential": 0.0,
      "baseline_neutrophil_lymphocyte_ratio": -0.2960061600674722,
      "charlson_comorbidity_index": -1.1840246402698889,
      "baseline_alt_level": -0.5920123201349444,
      "her2_status_positive": 0.5920123201349444,
      "her2_status_equivocal": 0.0,
      "insurance_type_medicare": -0.2960061600674722,
      "insurance_type_medicaid": -1.1840246402698889,
      "insurance_type_uninsured": -1.7760369604048334
    },
    "interactions": [
      {
        "terms": [
          "age",
          "charlson_comorbidity_index"
        ],
        "coefficient": -0.0394674880089963
      },
      {
        "terms": [
          "insurance_type_uninsured",
          "baseline_alt_level"
        ],
        "coefficient": -0.09866872002249076
      }
    ],
    "original_intercept": -0.2
  },
  "outcome_equation": {
    "intercept": -2.8876117189076997,
    "coefficients": {
      "age": 0.2188272316917905,
      "ecog_performance_status_1": 0.5470680792294762,
      "ecog_performance_status_2": 1.3676701980736905,
      "ecog_performance_status_3": 2.461806356532643,
      "visceral_metastasis_site_liver": 1.6412042376884286,
      "visceral_metastasis_site_lung": 1.0941361584589524,
      "visceral_metastasis_site_multiple_viscera": 2.188272316917905,
      "prior_adjuvant_endocrine_therapy_tamoxifen": 0.2735340396147381,
      "prior_adjuvant_endocrine_therapy_aromatase_inhibitor": -0.13676701980736905,
      "prior_adjuvant_endocrine_therapy_sequential": 0.0,
      "baseline_neutrophil_lymphocyte_ratio": 0.8206021188442143,
      "charlson_comorbidity_index": 1.0941361584589524,
      "baseline_alt_level": 0.5470680792294762,
      "her2_status_positive": 1.3676701980736905,
      "her2_status_equivocal": 0.5470680792294762,
      "insurance_type_medicare": 0.0,
      "insurance_type_medicaid": 0.2735340396147381,
      "insurance_type_uninsured": 0.5470680792294762
    },
    "interactions": [
      {
        "terms": [
          "baseline_neutrophil_lymphocyte_ratio",
          "charlson_comorbidity_index"
        ],
        "coefficient": 0.09117801320491273
      },
      {
        "terms": [
          "visceral_metastasis_site_multiple_viscera",
          "her2_status_positive"
        ],
        "coefficient": 0.18235602640982546
      }
    ],
    "treatment_coefficient": 0.2,
    "treatment_interactions": [
      {
        "term": "age",
        "coefficient": -0.22878365400843922
      },
      {
        "term": "ecog_performance_status_1",
        "coefficient": 0.8219046996297282
      },
      {
        "term": "ecog_performance_status_2",
        "coefficient": 0.4230549337988009
      },
      {
        "term": "ecog_performance_status_3",
        "coefficient": 0.17990969149788152
      },
      {
        "term": "menopausal_status_peri‑menopausal",
        "coefficient": -0.6272707388796671
      },
      {
        "term": "menopausal_status_post‑menopausal",
        "coefficient": -0.6273147233469609
      },
      {
        "term": "visceral_metastasis_site_liver",
        "coefficient": -0.8058611649039047
      },
      {
        "term": "visceral_metastasis_site_lung",
        "coefficient": 0.6677442690958216
      },
      {
        "term": "visceral_metastasis_site_multiple_viscera",
        "coefficient": 0.18438931751874393
      },
      {
        "term": "prior_adjuvant_endocrine_therapy_tamoxifen",
        "coefficient": 0.37943288491736127
      },
      {
        "term": "prior_adjuvant_endocrine_therapy_aromatase_inhibitor",
        "coefficient": -0.8742430661947447
      },
      {
        "term": "prior_adjuvant_endocrine_therapy_sequential",
        "coefficient": 0.856908934110898
      },
      {
        "term": "baseline_neutrophil_lymphocyte_ratio",
        "coefficient": 0.6062291898555382
      },
      {
        "term": "charlson_comorbidity_index",
        "coefficient": -0.5245669673022615
      },
      {
        "term": "baseline_alt_level",
        "coefficient": -0.5802113468292903
      },
      {
        "term": "her2_status_positive",
        "coefficient": -0.5773309556239885
      },
      {
        "term": "her2_status_equivocal",
        "coefficient": -0.35697606712798724
      },
      {
        "term": "insurance_type_medicare",
        "coefficient": 0.04514484500541401
      },
      {
        "term": "insurance_type_medicaid",
        "coefficient": -0.12410235977818515
      },
      {
        "term": "insurance_type_uninsured",
        "coefficient": -0.3807062442364783
      }
    ],
    "original_intercept": -1.2
  },
  "summary_statistics": {
    "age": {
      "type": "continuous",
      "mean": 63.8,
      "std": 11.4
    },
    "ecog_performance_status": {
      "type": "categorical",
      "proportions": {
        "0": 0.15,
        "1": 0.5,
        "2": 0.25,
        "3": 0.1
      }
    },
    "menopausal_status": {
      "type": "categorical",
      "proportions": {
        "pre-menopausal": 0.15,
        "peri-menopausal": 0.1,
        "post-menopausal": 0.75
      }
    },
    "visceral_metastasis_site": {
      "type": "categorical",
      "proportions": {
        "bone-only": 0.3,
        "liver": 0.25,
        "lung": 0.15,
        "multiple_viscera": 0.3
      }
    },
    "prior_adjuvant_endocrine_therapy": {
      "type": "categorical",
      "proportions": {
        "none": 0.2,
        "tamoxifen": 0.35,
        "aromatase_inhibitor": 0.3,
        "sequential": 0.15
      }
    },
    "baseline_neutrophil_lymphocyte_ratio": {
      "type": "continuous",
      "mean": 3.1,
      "std": 1.6
    },
    "charlson_comorbidity_index": {
      "type": "continuous",
      "mean": 4.2,
      "std": 2.1
    },
    "baseline_alt_level": {
      "type": "continuous",
      "mean": 32.0,
      "std": 14.5
    },
    "her2_status": {
      "type": "categorical",
      "proportions": {
        "negative": 0.85,
        "positive": 0.1,
        "equivocal": 0.05
      }
    },
    "insurance_type": {
      "type": "categorical",
      "proportions": {
        "private": 0.45,
        "medicare": 0.35,
        "medicaid": 0.15,
        "uninsured": 0.05
      }
    }
  },
  "dataset_statistics": {
    "n_patients": 1000,
    "treatment_rate": 0.485,
    "outcome_rate": 0.529,
    "mean_treatment_prob": 0.4944210872737587,
    "std_treatment_prob": 0.3092919925469562,
    "mean_outcome_prob": 0.5393090058731623,
    "std_outcome_prob": 0.29855066590402385,
    "mean_ite_prob": 0.01872371263087876,
    "std_ite_prob": 0.2375336948059155,
    "clinical_text_stats": {
      "non_empty_count": "1000",
      "mean_length": 8740.598
    }
  }
}